< BACK TO PRESS RELEASES LISTING
Montag, 27. Februar 2012
Houlihan Lokey Announces Closing of the Sale of Alacer Corp. to Pfizer Inc.
Serves as Exclusive Financial Advisor to Alacer
NEW YORK – February 27, 2012—Houlihan Lokey, an international investment bank, today announced the closing of the sale of Alacer Corp. to Pfizer Inc. Houlihan Lokey served as the exclusive financial advisor to Alacer, assisting with structuring and negotiating the transaction on their behalf. The sale will help expand Alacer’s accessibility to the global market, further building its leading dietary supplement business.
Alacer, headquartered in Foothill Ranch, Calif., is the manufacturer and marketer of Emergen-C, a health and wellness lifestyle brand that is well-known for its high quality, excellent tasting, naturally flavored and sweetened, nutritionally enhanced effervescent drink mixes. The Emergen-C brand is sold in the vitamin, mineral and supplement aisle at all leading U.S. retailers in the FDM and Health & Natural channels, including Walmart, Target, CVS, Walgreens, Whole Foods and Trader Joe’s, as well as in select retailers in Canada.
“We are excited to have advised Alacer on this particular business venture, assisting with developing, formulating and executing an appropriate strategy for the company,” said William Hood, Director, Consumer, Food & Retail Group in New York. “Houlihan Lokey continues to use its extensive experience, in-depth industry knowledge and relationships, as well as global reach to assist clients in achieving their strategic objectives.”
“Today marks the beginning of an exciting new chapter for Alacer and the Emergen-C health and wellness brand. It is a unique opportunity to join one of the world's top performing consumer healthcare businesses,” said Ron Fugate, President and CEO of Alacer. “By becoming part of Pfizer, we can access the resources and reach that will help us support healthy, active lifestyles across the globe.”
The transaction closed on February 27, 2012. Rutan & Tucker, LLP served as the legal advisor to Alacer.
Houlihan Lokey has a strong track record in the consumer, food and retail space and was ranked No. 1 for all U.S. Consumer, Food & Retail transactions in 2011 by Thomson Reuters.
Houlihan Lokey (NYSE:HLI) is a global investment bank with expertise in mergers and acquisitions, capital markets, financial restructuring, valuation, and strategic consulting. The firm serves corporations, institutions, and governments worldwide with offices in the United States, Europe, and the Asia-Pacific region. Independent advice and intellectual rigor are hallmarks of the firm's commitment to client success across its advisory services. Houlihan Lokey is ranked as the No. 1 M&A advisor for all U.S. transactions, the No. 1 global restructuring advisor, and the No. 1 global M&A fairness opinion advisor over the past 20 years, according to Thomson Reuters.
For press inquiries, contact
PR@HL.com or +1.212.331.8223.